Peptide Therapy Providers in Bismarck, North Dakota

1 provider found in Bismarck · 1 offer telehealth · 1 free consultations

PeptideProbe lists 1 peptide therapy provider in Bismarck, North Dakota. Whether you're researching GLP-1 weight-loss medications like semaglutide and tirzepatide, recovery peptides such as BPC-157, or hormone optimization protocols, you can compare clinics below by services offered, telehealth availability, insurance acceptance, and patient reviews. 1 offers a free initial consultation.

Most-offered peptides in Bismarck: Semaglutide (1), Sermorelin (1), Tirzepatide (1), BPC-157 (1), Ipamorelin (1).

Bismarck, ND
TelehealthFree Consult
SemaglutideSermorelinTirzepatideBPC-157Ipamorelin

Simply You Wellness is a personalized provider for health and wellness in Bismarck specializing in peptide therapy, family medicine, men's health, and women's healthcare. They offer hormone health exp

View Profile

Nearby Cities in North Dakota

Frequently Asked Questions

Peptide therapy costs in Bismarck, North Dakota vary by treatment. Semaglutide typically costs $200-$500/month. Other peptides range from $100-$800/month depending on the specific therapy and provider.

Yes, 1 of 1 providers in Bismarck Bismarck, North Dakota offer telehealth services. This allows you to consult with practitioners remotely and have medications shipped directly to you.

Providers in Bismarck commonly offer weight-loss peptides (semaglutide, tirzepatide), recovery peptides (BPC-157, TB-500), anti-aging treatments (NAD+, GHK-Cu), and hormone optimization therapies (sermorelin, CJC-1295).

Yes — peptide therapies in Bismarck require a prescription from a licensed healthcare provider. This includes FDA-approved GLP-1 medications and compounded peptides from licensed pharmacies. All providers listed on PeptideProbe operate under licensed medical supervision.

Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.